Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure

American Journal of Cardiology

Volumn 106, Issue 12, 2010, Pages 1770-1776

  Kapur, Navin K ^a   Heffernan, Kevin S ^a   Yunis, Adil A ^a   Parpos, Peter ^a   Kiernan, Michael S ^a   Sahasrabudhe, Nikhil A ^a   Kimmelstiel, Carey D ^a   Kass, David A ^b   Karas, Richard H ^a   Mendelsohn, Michael E ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOGLIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIURESIS; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEMODYNAMIC MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULMONARY ARTERY OCCLUSION PRESSURE;

ANTIGENS, CD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART FAILURE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 78649710043     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.08.018     Document Type: Article

References (22)

1. S. Cheifetz, T. Belln, C. Cals, S. Vera, C. Bernabeu, J. Massagu, and M. Letarte Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells J Biol Chem 267 1992 19027 19030
2. F. Lebrin, M.J. Goumans, L. Jonker, R.L. Carvalho, G. Valdimarsdottir, M. Thorikay, C. Mummery, H.M. Arthur, and P. Ten Dijke Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction EMBO J 23 2004 4018 4028
3. S. St.-Jacques, U. Cymerman, N. Pece, and M. Letarte Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells Endocrinology 134 1994 2645 2657
4. S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, Y.M. Kim, Y. Bdolah, K.H. Lim, H.T. Yuan, T.A. Libermann, I.E. Stillman, D. Roberts, P.A. D'Amore, F.H. Epstein, F.W. Sellke, R. Romero, V.P. Sukhatme, M. Letarte, and S.A. Karumanchi Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649 (Pubitemid 43865232)
5. A. Leask, D.J. Abraham, D.R. Finlay, A. Holmes, D. Pennington, X. Shi-Wen, Y. Chen, K. Venstrom, X. Dou, M. Ponticos, C. Black, C. Bernabeu, J.K. Jackman, P.R. Findell, and M.K. Connolly Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts Arthritis Rheum 46 2002 1857 1865
6. A. Rodrguez-Pea, N. Eleno, A. Dwell, M. Arvalo, F. Prez-Barriocanal, O. Flores, N. Docherty, C. Bernabeu, M. Letarte, and J.M. Lpez-Novoa Endoglin upregulation during experimental renal interstitial fibrosis in mice Hypertension 40 2002 713 720
7. E. Yagmur, M. Rizk, S. Stanzel, C. Hellerbrand, F. Lammert, C. Trautwein, H.E. Wasmuth, and A.M. Gressner Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma Eur J Gastroenterol Hepatol 19 2007 755 761
8. L. Diez-Marques, R. Ortega-Velazquez, C. Langa, A. Rodriguez-Barbero, J.M. Lopez-Novoa, S. Lamas, and C. Bernabeu Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis Biochim Biophys Acta 1587 2002 36 44
9. E.M. Zeisberg, O. Tarnavski, M. Zeisberg, A.L. Dorfman, J.R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W.T. Pu, A.B. Roberts, E.G. Neilson, M.H. Sayegh, S. Izumo, and R. Kalluri Endothelial-to-mesenchymal transition contributes to cardiac fibrosis Nat Med 13 2007 952 961
10. S. Rosenkranz TGF-beta1 and angiotensin networking in cardiac remodeling Cardiovasc Res 63 2004 423 432
11. D.L. Brutsaert Role of endocardium in cardiac overloading and failure Eur Heart J 11 1990 G8 G16
12. E.M. Zeisberg, O. Tarnavski, M. Zeisberg, A.L. Dorfman, J.R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W.T. Pu, A.B. Roberts, E.G. Neilson, M.H. Sayegh, S. Izumo, and R. Kalluri Endothelial-to-mesenchymal transition contributes to cardiac fibrosis Nat Med 13 2007 952 961
13. R. Khan Examining potential therapies targeting myocardial fibrosis through the inhibition of transforming growth factor-beta. 1 Cardiology 108 2007 368 380
14. B. Valeria, G. Maddalena, V. Enrica, T. Onofrio, and B. Gaetano Endoglin (CD105) expression in the human heart throughout gestation: an immunohistochemical study Reprod Sci 15 2008 1018 1026
15. R.S. Foo, K. Mani, and R.N. Kitsis Death begets failure in the heart J Clin Invest 115 2005 565 571
16. D.Y. Li, L.K. Sorensen, B.S. Brooke, L.D. Urness, E.C. Davis, D.G. Taylor, B.B. Boak, and D.P. Wendel Defective angiogenesis in mice lacking endoglin Science 284 1999 1534 1537
17. K.A. McAllister, K.M. Grogg, D.W. Johnson, C.J. Gallione, M.A. Baldwin, C.E. Jackson, E.A. Helmbold, D.S. Markel, W.C. McKinnon, and J. Murrell Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat Genet 8 1994 345 351
18. Y. Zhu, Y. Sun, L. Xie, K. Jin, N. Sheibani, and D.A. Greenberg Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells Stroke 34 2003 2483 2488
19. L.M. Botella, T. Snchez-Elsner, F. Sanz-Rodriguez, S. Kojima, J. Shimada, M. Guerrero-Esteo, M.P. Cooreman, V. Ratziu, C. Langa, C.P. Vary, J.R. Ramirez, S. Friedman, and C. Bernabu Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury Blood 100 2002 4001 4010
20. A.H. Wu, A. Smith, and S. Wieczore Biological variation for N-terminal pro- and B-type natriuretic peptides and implications of the therapeutic monitoring of patients with congestive heart failure Am J Cardiol 92 2003 628 631
21. P.R. Forfia, S.P. Watkins, and J.E. Rame Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit J Am Coll Cardiol 45 2005 1667 1671
22. A.I. Larsen, K. Dickstein, N.S. Ahmadi, T. Aarsland, J.T. Kvaløy, and C. Hall The effect of altering hemodynamics on the plasma concentrations of natriuretic peptides in heart failure Eur J Heart Fail 8 2006 628 633